University of Hertfordshire

From the same journal

By the same authors

5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'

Research output: Contribution to journalArticle

View graph of relations
Original languageEnglish
Number of pages7
Pages (from-to)106-112
JournalHuman Psychopharmacology
Journal publication date1 Mar 2012
Volume27
Issue2
DOIs
Publication statusPublished - 1 Mar 2012

Abstract

The fully synthetic 'legal high' 5,6-methylenedioxy-2-aminoindane (MDAI) is an analogue of 3,4-methylenedioxymethamphetamine. Although developed in the 1990s, it was not widely abused until 2010. However, mephedrone was banned in the UK in April 2010, and almost immediately, MDAI was widely advertised as a legal alternative. This paper provides both an overview of the current state of knowledge of MDAI and a critical analysis of online available information relating to its psychoactive effects, adverse reactions and use in combination with other drugs.

ID: 668827